05:49 PM EDT, 04/10/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said Wednesday it completed the acquisition of AnHeart Therapeutics, a late-stage oncology drugmaker.
Shareholders of Nuvation and AnHeart immediately before closing now own about 67% and 33%, respectively, of Nuvation.
Shares of Nuvation rose about 2.6% in after-hours activity.
Price: 3.13, Change: +0.08, Percent Change: +2.62